Clinical Trial

Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes in COPD Patients

Study acronym: PLB I:E Ratio
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2026 (before its estimated August 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate whether different inspiratory-expiratory (I:E) ratios in the pursed-lip breathing (PLB) technique can improve respiratory outcomes in patients with stable Chronic Obstructive Pulmonary Disease (COPD) aged 40 years and older. The primary purpose is to determine whether a specific breathing intervention can improve respiratory function. The main questions it aims to answer are: Does PLB with different I:E ratios (1:3, 1:4, and 1:5) reduce respiratory rate in COPD patients? Does PLB with different I:E ratios improve oxygen saturation and reduce dyspnea severity? Researchers will compare PLB with I:E ratios of 1:3, 1:4, and 1:5 and a control group receiving standard care to see if different ratios produce different effects on respiratory rate, oxygen saturation, and dyspnea levels. Participants will: Perform pursed-lip breathing using assigned I:E ratios (1:3, 1:4, or 1:5) for 10 minutes Be assigned to either an intervention group or a control group (standard care) Have their respiratory rate measured before and after the intervention Have their oxygen saturation measured using a pulse oximeter Report their dyspnea level using the Modified Borg Scale before and after the intervention
Trial Details
NCT Number NCT07573826
Lead Sponsor Scholastica Fina Aryu Puspasari
Collaborators: STIKes Panti Rapih Yogyakarta
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 122 participants
Start Date 2026-05-04
Primary Completion 2026-08-07 (estimated)
Study Completion 2026-08-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-07